<?xml version="1.0" encoding="UTF-8"?>
<p>The urge to find a therapy for SARS-CoV-2 infection determined the occurrence of multiple therapeutic alternatives, such as repurposed drugs, broad-spectrum antivirals (remdesivir, lopinavir/ritonavir, oseltamivir, and so on), antimalarial drugs (chloroquine and hydroxychloroquine), anti-inflammatory compounds (baricitinib, fedratinib, ruxolitinib, sunitinib), anticoagulants (low molecular weight heparin, unfractionated heparin), convalescent plasma, and novel potential antivirals (vaccines, anti-SARS-CoV-2 antibodies, natural compounds, and so on).</p>
